Updates are available Correction dated 2023-06-22
Click to view Correction: https://doi.org/10.1038/s41596-023-00862-3
-
Authors
Ge, Ruiqi
Ye, Chang http://orcid.org/0000-0003-0236-5671
Peng, Yong
Dai, Qing http://orcid.org/0000-0002-8578-1568
Zhao, Yutao
Liu, Shun
Wang, Pingluan
Hu, Lulu
He, Chuan http://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RM1 HG008935, RM1 HG008935, R01CA251150, RM1 HG008935, R01CA251150, RM1 HG008935, R01CA251150, RM1 HG008935, R01CA251150, RM1 HG008935, R01CA251150, RM1 HG008935, R01CA251150, RM1 HG008935, R01CA251150)
Howard Hughes Medical Institute
National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund
- License Information
-
More Information
Article History
Received: 18 March 2022
Accepted: 22 July 2022
First Online: 25 November 2022
Competing interests
: A patent application for m<sup>6</sup>A-SAC-seq has been filed by the University of Chicago. C.H. is a scientific founder and a scientific advisory board member of Accent Therapeutics, Inc. and Inferna Green, Inc.
